Literature DB >> 28496898

Durable Pulmonary Vein Isolation: The Holy Grail of Atrial Fibrillation Ablation.

Duy Thai Nguyen1, William H Sauer1.   

Abstract

The inability to achieve durable pulmonary vein isolation remains a major limitation to catheter ablation for the treatment of atrial fibrillation (AF). In this review, we discuss the research performed over the past decade investigating methods to improve lesion permanence for the goal of durable pulmonary vein isolation (PVI). Investigations evaluating procedural techniques, adjunctive pharmacologic therapy, and newer energy sources designed to improve ablation lesion permanence are discussed.

Entities:  

Keywords:  Ablation; Atrial Fibrillation; Durability; Pulmonary vein

Year:  2013        PMID: 28496898      PMCID: PMC5153040          DOI: 10.4022/jafib.927

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  40 in total

1.  Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.

Authors:  Bernhard Richter; Michael Derntl; Manfred Marx; Peter Lercher; Heinz D Gössinger
Journal:  Am Heart J       Date:  2007-01       Impact factor: 4.749

2.  Cryoballoon ablation of paroxysmal atrial fibrillation: 5-year outcome after single procedure and predictors of success.

Authors:  Thomas Neumann; Maciej Wójcik; Alexander Berkowitsch; Damir Erkapic; Sergey Zaltsberg; Harald Greiss; Dimitri Pajitnev; Stefan Lehinant; Jörn Schmitt; Christian W Hamm; Heinz F Pitschner; Malte Kuniss
Journal:  Europace       Date:  2013-02-17       Impact factor: 5.214

3.  Loss of pace capture on the ablation line: a new marker for complete radiofrequency lesions to achieve pulmonary vein isolation.

Authors:  Daniel Steven; Vivek Y Reddy; Keiichi Inada; Kurt C Roberts-Thomson; Jens Seiler; William G Stevenson; Gregory F Michaud
Journal:  Heart Rhythm       Date:  2009-11-12       Impact factor: 6.343

4.  Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers have no beneficial effect on ablation outcome in chronic persistent atrial fibrillation.

Authors:  Bin Zheng; Junping Kang; Ying Tian; Ribo Tang; Deyong Long; Ronghui Yu; Hua He; Ming Zhang; Lisheng Shi; Hailong Tao; Xingpeng Liu; Jianzeng Dong; Changsheng Ma
Journal:  Acta Cardiol       Date:  2009-06       Impact factor: 1.718

5.  The permanency of pulmonary vein isolation using a balloon cryoablation catheter.

Authors:  Humera Ahmed; Petr Neuzil; Jan Skoda; Andre D'Avila; David M Donaldson; Margaret C Laragy; Vivek Y Reddy
Journal:  J Cardiovasc Electrophysiol       Date:  2010-02-01

6.  Catheter ablation of atrial fibrillation without fluoroscopy using intracardiac echocardiography and electroanatomic mapping.

Authors:  John D Ferguson; Adam Helms; J Michael Mangrum; Srijoy Mahapatra; Pamela Mason; Ken Bilchick; George McDaniel; David Wiggins; John P DiMarco
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-12

7.  Mechanisms of organized left atrial tachycardias occurring after pulmonary vein isolation.

Authors:  Edward P Gerstenfeld; David J Callans; Sanjay Dixit; Andrea M Russo; Hemal Nayak; David Lin; Ward Pulliam; Sultan Siddique; Francis E Marchlinski
Journal:  Circulation       Date:  2004-09-07       Impact factor: 29.690

8.  Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial.

Authors:  Douglas L Packer; Robert C Kowal; Kevin R Wheelan; James M Irwin; Jean Champagne; Peter G Guerra; Marc Dubuc; Vivek Reddy; Linda Nelson; Richard G Holcomb; John W Lehmann; Jeremy N Ruskin
Journal:  J Am Coll Cardiol       Date:  2013-03-21       Impact factor: 24.094

9.  Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats.

Authors:  M C Wijffels; C J Kirchhof; R Dorland; M A Allessie
Journal:  Circulation       Date:  1995-10-01       Impact factor: 29.690

10.  Early identification and treatment of PV re-connections: role of observation time and impact on clinical results of atrial fibrillation ablation.

Authors:  Xin-hua Wang; Xu Liu; Yu-min Sun; Jia-ning Gu; Hai-feng Shi; Li Zhou; Wei Hu
Journal:  Europace       Date:  2007-05-23       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.